{"id":231088,"date":"2026-02-11T01:37:23","date_gmt":"2026-02-11T07:37:23","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/02\/discovery-of-unique-brain-tumor-subtypes-offers-hope-for-targeted-glioma-therapies"},"modified":"2026-02-11T01:37:23","modified_gmt":"2026-02-11T07:37:23","slug":"discovery-of-unique-brain-tumor-subtypes-offers-hope-for-targeted-glioma-therapies","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/02\/discovery-of-unique-brain-tumor-subtypes-offers-hope-for-targeted-glioma-therapies","title":{"rendered":"Discovery of unique brain tumor subtypes offers hope for targeted glioma therapies"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/discovery-of-unique-brain-tumor-subtypes-offers-hope-for-targeted-glioma-therapies2.jpg\"><\/a><\/p>\n<p>Researchers have uncovered the mechanisms behind three unique subtypes of mismatch repair deficient high-grade gliomas. The findings provide a clearer understanding of how these tumors develop, explain why patients respond differently to immunotherapy, and are already helping guide more precise therapies.<\/p>\n<p>High-grade gliomas are a group of aggressive brain tumors and one of the deadliest tumors in children and young adults. In some children, the tumors are driven by mismatch repair deficiency (MMRD), which is characterized by hypermutation (a large and quickly accumulating number of mutations in tumor cells) and resistance to standard treatments such as chemotherapy and radiation.<\/p>\n<p>Tumors driven by mismatch repair deficiency are known as primary mismatch repair deficient high\u2011grade gliomas (priMMRD\u2011HGG). Because priMMRD-HGG have high numbers of mutations, treatment has shifted to immunotherapy, which uses the body\u2019s own immune system to fight cancer by targeting cancer cells.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Researchers have uncovered the mechanisms behind three unique subtypes of mismatch repair deficient high-grade gliomas. The findings provide a clearer understanding of how these tumors develop, explain why patients respond differently to immunotherapy, and are already helping guide more precise therapies. High-grade gliomas are a group of aggressive brain tumors and one of the deadliest [\u2026]<\/p>\n","protected":false},"author":427,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-231088","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/231088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/427"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=231088"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/231088\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=231088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=231088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=231088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}